Fidelity Investments’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13B | Buy |
4,373,987
+24,359
| +0.6% | +$6.48M | 0.06% | 259 |
|
|
2025
Q4 | $1.07B | Buy |
4,349,628
+8,181
| +0.2% | +$1.72M | 0.05% | 273 |
|
|
2025
Q3 | $766M | Buy |
4,341,447
+6,686
| +0.2% | +$1M | 0.04% | 372 |
|
|
2025
Q2 | $596M | Buy |
4,334,761
+13,929
| +0.3% | +$2.05M | 0.03% | 421 |
|
|
2025
Q1 | $779M | Buy |
4,320,832
+6,818
| +0.2% | +$1.15M | 0.05% | 311 |
|
|
2024
Q4 | $676M | Buy |
4,314,014
+21,133
| +0.5% | +$3.75M | 0.04% | 361 |
|
|
2024
Q3 | $781M | Buy |
4,292,881
+9,115
| +0.2% | +$1.76M | 0.05% | 336 |
|
|
2024
Q2 | $787M | Buy |
4,283,766
+39,874
| +0.9% | +$6.69M | 0.05% | 305 |
|
|
2024
Q1 | $755M | Buy |
4,243,892
+1,857,994
| +78% | +$258M | 0.05% | 335 |
|
|
2023
Q4 | $296M | Sell |
2,385,898
-243,485
| -9% | -$27M | 0.02% | 596 |
|
|
2023
Q3 | $305M | Sell |
2,629,383
-52,214
| -2% | -$6.37M | 0.03% | 551 |
|
|
2023
Q2 | $315M | Buy |
2,681,597
+484,639
| +22% | +$49.5M | 0.03% | 561 |
|
|
2023
Q1 | $176M | Buy |
2,196,958
+88,105
| +4% | +$6.92M | 0.02% | 760 |
|
|
2022
Q4 | $167M | Buy |
2,108,853
+2,419
| +0.1% | +$180K | 0.02% | 759 |
|
|
2022
Q3 | $147M | Buy |
2,106,434
+178
| +0% | +$12.9K | 0.02% | 800 |
|
|
2022
Q2 | $138M | Sell |
2,106,256
-236
| -0% | -$14.7K | 0.01% | 833 |
|
|
2022
Q1 | $140M | Buy |
2,106,492
+128,203
| +6% | +$8M | 0.01% | 933 |
|
|
2021
Q4 | $138M | Buy |
1,978,289
+75,884
| +4% | +$4.42M | 0.01% | 947 |
|
|
2021
Q3 | $99.3M | Buy |
1,902,405
+134,488
| +8% | +$7.96M | 0.01% | 1111 |
|
|
2021
Q2 | $120M | Buy |
1,767,917
+426,020
| +32% | +$29.7M | 0.01% | 1042 |
|
|
2021
Q1 | $103M | Buy |
1,341,897
+89,511
| +7% | +$6.51M | 0.01% | 1051 |
|
|
2020
Q4 | $75.1M | Sell |
1,252,386
-76,900
| -6% | -$3.84M | 0.01% | 1154 |
|
|
2020
Q3 | $57.2M | Hold |
1,329,286
| – | – | 0.01% | 1142 |
|
|
2020
Q2 | $55.1M | Buy |
1,329,286
+181,000
| +16% | +$8.71M | 0.01% | 1120 |
|
|
2020
Q1 | $49.7M | Hold |
1,148,286
| – | – | 0.01% | 1031 |
|
|
2019
Q4 | $63.6M | Hold |
1,148,286
| – | – | 0.01% | 1107 |
|
|
2019
Q3 | $39.9M | Hold |
1,148,286
| – | – | ﹤0.01% | 1275 |
|
|
2019
Q2 | $46.2M | Sell |
1,148,286
-87,114
| -7% | -$2.85M | 0.01% | 1260 |
|
|
2019
Q1 | $40.6M | Hold |
1,235,400
| – | – | ﹤0.01% | 1299 |
|
|
2018
Q4 | $25.7M | Buy |
1,235,400
+300,000
| +32% | +$6.28M | ﹤0.01% | 1457 |
|
|
2018
Q3 | $16.4M | Sell |
935,400
-264,600
| -22% | -$4.44M | ﹤0.01% | 1763 |
|
|
2018
Q2 | $17.8M | Hold |
1,200,000
| – | – | ﹤0.01% | 1759 |
|
|
2018
Q1 | $12.1M | Hold |
1,200,000
| – | – | ﹤0.01% | 1904 |
|
|
2017
Q4 | $12.6M | Hold |
1,200,000
| – | – | ﹤0.01% | 1880 |
|
|
2017
Q3 | $12M | Buy |
+1,200,000
| New | +$12.1M | ﹤0.01% | 1883 |
|
Other funds holding KRYS
ACA
VPM
VCM
SCM
RG
HRCM